Trump Announces Deal With AstraZeneca to Lower Drug Prices

The U.K.-based company will offer discount pricing to low-income Americans and make a $50 billion investment in U.S. manufacturing.

President Donald Trump (R) speaks in the Oval Office of the White House with (L-R) U.S. Commerce Secretary Howard Lutnick, Health and Human Services Secretary Robert F. Kennedy Jr., and Virginia Gov. Glenn Youngkin on Oct. 10, 2025. Andrew Harnik/Getty Images

President Donald Trump announced on Oct. 10 an agreement with AstraZeneca to lower drug prices in the United States.

The U.K.-based pharmaceutical manufacturer will offer most-favored-nation drug pricing on all medications to Medicaid recipients, guaranteeing them the lowest price available in any developed country.